Ayad Hamdan

Hematology

330 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

QIM26-301: Implementation of a Same-Day Cancer Care Clinic at an Academic Medical Center.

QIM26-301: Implementation of a Same-Day Cancer Care Clinic at an Academic Medical Center.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

BIO26-035: Validation of an Electronic Health Record Phenotype for Advanced Solid Cancer Across Five University of California Health Systems.

BIO26-035: Validation of an Electronic Health Record Phenotype for Advanced Solid Cancer Across Five University of California Health Systems.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2026

QIM26-301: Implementation of a Same-Day Cancer Care Clinic at an Academic Medical Center.

QIM26-301: Implementation of a Same-Day Cancer Care Clinic at an Academic Medical Center.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 31, 2026

BIO26-035: MTAP Deficiency in Thoracic Oncology: Bridging Genomic Loss, Survival Deficits, and Immunosuppressive Microenvironments.

BIO26-035: MTAP Deficiency in Thoracic Oncology: Bridging Genomic Loss, Survival Deficits, and Immunosuppressive Microenvironments.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.

A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.

Journal: Blood advances

Published: October 17, 2024

Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience.

Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience.

Journal: Cancers

Published: July 08, 2023

Adjuvant low-dose rituximab and plasma exchange for acquired TTP.

Adjuvant low-dose rituximab and plasma exchange for acquired TTP.

Journal: Blood

Published: June 28, 2019

DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma.

DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: September 30, 2017

Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.

Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.

Journal: PloS one

Published: August 01, 2017

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.

Journal: Blood

Published: May 11, 2017

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.

Journal: The Journal of infectious diseases

Published: March 06, 2017

Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.

Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.

Journal: Transfusion

Published: January 04, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026